Register to read this story and more for free. Signing up for an account helps us improve your browsing experience.

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual ...

CamScanner Celebrates National Techies Day with Powerful AI Features and Campus Empowerment Program ...

Epilepsy Foundation announced today it has awarded $200,000 in funding for two startups who competed in the Foundation's 2024 ...

-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in ...

Integer Holdings Corporation to Divest Non-Medical Business for $50 million ...

Notice to General Meeting to be held 22 October 2024. See attached announcement 371.

Osisko Announces Agreement to Purchase Royalties on Spartan Resources' Dalgaranga Gold Project in Western Australia ...

As part of the investment, Personal AI will partner with BDev Ventures' proprietary lead generation platform, WinDifferent, ...

Thermore presents Invisiloft®: the innovative slim insulation offering high warmth with minimal thickness ...

BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type ...

Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis ...